Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.60 |
| ▸ | CA12 | O43570 | 11/20 | 0.55 |
| ▸ | CA2 | P00918 | 6/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 10/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.39 |
| ▸ | UGT1A7 | Q9HAW7 | 1/20 | 0.39 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL584421 | 0.90 | CA1 (0.50) | CA1CA12CA2CA14CA9 | |
| SCHEMBL28476788 | 0.90 | CA1 (0.50) | CA1CA12CA2CA14CA9 | |
| SCHEMBL5252426 | 0.89 | CA1 (0.55) | CA1CA12CA2CA14CA9 | |
| SCHEMBL27829031 | 0.87 | CA1 (0.52) | CA1CA12CA2CA14CA9 | |
| SCHEMBL1035915 | 0.86 | CA1 (0.43) | CA1CA12CA2CA14CA9 | |
| SCHEMBL8428252 | 0.85 | CA1 (0.50) | CA1CA12CA2CA14CA9 | |
| SCHEMBL11580213 | 0.85 | CA1 (0.50) | CA1CA12CA2CA14CA9 | |
| SCHEMBL27564460 | 0.83 | CA1 (0.42) | CA1CA12CA2CA14CA9 | |
| SCHEMBL5252089 | 0.83 | CA1 (0.42) | CA1CA12CA2CA14CA9 | |
| Hydrochloric Acid SCHEMBL10538290 | 0.83 | CA1 (0.42) | CA1CA12CA2CA14CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103911615-B | Etching agent composite for copper-containing metal | 东友精细化工有限公司 | 2017-08-22 | — | — | CN | claimed |
| US-4140684-A | FOR POLYESTERS, POLYAMIDES, AND CELLULOSE ACETATES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1979-02-20 | — | — | US | claimed |
| US-12606464-B2 | Membrane separation method | KURITA WATER INDUSTRIES LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-4635610-A1 | MEMBRANE TREATMENT METHOD AND BIOFOULING SUPPRESSION METHOD | Kurita Water Industries Ltd. (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-12303833-B2 | Reverse osmosis membrane treatment system and reverse osmosis membrane treatment method | ORGANO CORPORATION (JP) | 2025-05-20 | — | — | US | disclosed |
| US-12083480-B2 | Method for controlling slime in reverse osmosis membrane apparatus | KURITA WATER INDUSTRIES LTD. (JP) | 2024-09-10 | — | — | US | disclosed |
| WO-2024128050-A1 | MEMBRANE TREATMENT METHOD AND BIOFOULING SUPPRESSION METHOD | 栗田工業株式会社 | 2024-06-20 | — | — | WO | disclosed |
| US-20240083779-A1 | METHOD FOR OPERATING REVERSE OSMOSIS MEMBRANE DEVICE, A SLIME CONTROL METHOD, AND A WATER TREATMENT DEVICE | KURITA WATER INDUSTRIES LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11916195-B2 | Electrolyte solution, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| EP-4317083-A1 | METHOD FOR OPERATING REVERSE OSMOSIS MEMBRANE DEVICE | Kurita Water Industries Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20240025772-A1 | MEMBRANE SEPARATION METHOD | KURITA WATER INDUSTRIES LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-0765314-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995034540-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-12-21 | — | — | WO | disclosed |
| US-5292630-A | Red sensitive | FUJI PHOTO FILM CO., LTD. (JP) | 1994-03-08 | — | — | US | disclosed |
| EP-0556777-A1 | Silver halide color photographic material containing an imidazotriazole cyan coupler | FUJI PHOTO FILM CO., LTD. (JP) | 1993-08-25 | — | — | EP | disclosed |
| US-4552836-A | CYAN DYE FORMING COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-12 | — | — | US | disclosed |
| US-4179435-A | SULPHONIC ACID-FREE | CIBA-GEIGY CORPORATION (US) | 1979-12-18 | — | — | US | disclosed |
| US-4145340-A | WATER-SOLUBLE REACTIVE MONOAZO DYE CONTAINING A NONYLPHENOXY, CHLOROTRIAZINE GROUP | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-03-20 | — | — | US | disclosed |
| US-4140684-A | FOR POLYESTERS, POLYAMIDES, AND CELLULOSE ACETATES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1979-02-20 | — | — | US | disclosed |
| US-4115381-A | FOR POLYESTER FIBERS | CIBA-GEIGY CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606464-B2 | Membrane separation method | CLIC4, DUOX2, CLIC1 | CA1 359/4885CA12 407/4885CA2 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.